Non-clinical safety evaluation of coenzyme I (NAD⁺): A GLP-compliant systematic study

Jingliang Gu, Jie Xu, Shijun Yang, Yuyang Qiu, Lili Yin, Nannan Xu

Open source

DOI
10.1016/j.biopha.2026.119934
Published
2026-11
Container
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2026.119934,
  title = {Non-clinical safety evaluation of coenzyme I (NAD⁺): A GLP-compliant systematic study},
  author = {Jingliang Gu and Jie Xu and Shijun Yang and Yuyang Qiu and Lili Yin and Nannan Xu},
  year = {2026},
  journal = {Biomedicine \& Pharmacotherapy},
  doi = {10.1016/j.biopha.2026.119934},
  url = {https://doi.org/10.1016/j.biopha.2026.119934}
}

RIS

TY  - JOUR
TI  - Non-clinical safety evaluation of coenzyme I (NAD⁺): A GLP-compliant systematic study
AU  - Jingliang Gu
AU  - Jie Xu
AU  - Shijun Yang
AU  - Yuyang Qiu
AU  - Lili Yin
AU  - Nannan Xu
PY  - 2026
JO  - Biomedicine & Pharmacotherapy
DO  - 10.1016/j.biopha.2026.119934
UR  - https://doi.org/10.1016/j.biopha.2026.119934
ER  - 

APA

Gu, J., Xu, J., Yang, S., Qiu, Y., Yin, L., & Xu, N. (2026). Non-clinical safety evaluation of coenzyme I (NAD⁺): A GLP-compliant systematic study. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119934

Source records